Market News
Stay updated with the latest market trends, earnings, and economic indicators.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Bernstein bets on Indian healthcare, sees these three stocks as key beneficiaries
According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of 30.5 times its one-year forward earnings. However, it noted that its preferred stocks continue to trade below their long-term average valuations.

Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Sensex sheds 117 points after RBI policy; healthcare stocks buck trend
The S&P BSE Sensex declined 116.67 points or 0.16% to 74,243.34. The Nifty 50 index slipped 49.85 points or 0.21% to 23,366.70.
Market ends with minor cuts; Nifty settles below 23,400 level
The Nifty settled below the 23,400 mark. Metal, IT and oil & gas stocks witnessed selling pressure, while media, healthcare and realty shares attracted buying interest.

Leapfrog, IFC and NIIF eye ₹400 crore minority stake in Marengo Asia Healthcare
Marengo will likely use the proceeds to fund its next level growth phase, including inorganic growth plans and expanding its Gurgaon and Faridabad capacity

Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.
Board of Blue Jet Healthcare approves fund raising up to Rs 1,000 cr via equity route
At meeting held on 25 May 2026

Blue Jet Healthcare Q4 Results: Stock gains 10% despite weak earnings; Board approves fund raise
For the March quarter, Blue Jet Healthcare's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) fell 49% to ₹71 crore from ₹140 crore a year ago, while EBITDA margin contracted sharply to 30.3% from 41%. Yet, the stock was up 10%.